A Phase II Study in Pregnant Women to Assess the Safety and Immunogenicity of an Unadjuvanted Sanofi Pasteur H1N1 Inactivated Influenza Vaccine Administered at Two Dose Levels.
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2012
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 24 Jun 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 24 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Apr 2010 Actual patient number (121) added as reported by ClinicalTrials.gov.